caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1780664714

Jill BorovanskyM.D.

PRACTICEMAYO CLINIC ARIZONASee all providers at this practice →
Internal MedicineScottsdale, AZI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Jill Borovansky's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 24 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
MAYO CLINIC ARIZONA233805
BARR, KATHRYN59100
CHIVERS, F45187
KRANSDORF, MARK41140
LEE, HOWARD3171
Prasad Panse
Diagnostic Radiology · Scottsdale, AZ
29102
KUHLMAN, BENJAMIN2956
Ameet Patel
Diagnostic Radiology · Scottsdale, AZ
2391
Ryan Robetorye
Pathology · Scottsdale, AZ
2362
Mayo Collaborative Services, Inc
Clinical Laboratory · Rochester, MN
2259
Kelley Kennedy
Internal Medicine · Scottsdale, AZ
2048
RUZICH, RUSSELL1841
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,314
Unique beneficiaries
—
Total services
1,536
Distinct HCPCS
15
Medicare payment
$108K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 1,880 Internal Medicine providers in AZ — top quintile (cohort median 646).
PRESCRIBING · PART D · 2024
Total Rx claims
3,217
Beneficiaries
—
Total drug cost
$239K
Distinct drugs
72
Brand share
17.7%
Top prescribed drugs
Atorvastatin Calcium255 claims
Rosuvastatin Calcium227 claims
Levothyroxine Sodium213 claims
Amlodipine Besylate172 claims
Losartan Potassium127 claims
QUALITY · MIPS · 2024
Final MIPS score
86.5
Quality
78.3
Cost
76.6
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.48%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.